Actively Recruiting
Evaluation of a Type I Collagen-Based Medical Device for Treating Thumb Base Osteoarthritis A Pilot Study on Performance and Safety of MD-Small Joints Collagen Medical Device
Led by Guna S.p.a · Updated on 2025-01-17
42
Participants Needed
1
Research Sites
71 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Collagen is a key structural protein found in skin, cartilage, bone, and joints, known for its strength and flexibility. This research investigates a medical device called MD-Small Joints Collagen Medical Device, which uses type I collagen from swine, for treating symptomatic thumb base osteoarthritis. The study aims to evaluate the device's performance and safety in reducing pain and improving joint function in affected patients through a multicenter clinical investigation. Participants will receive a series of five injections of the collagen-based medical device. The first three injections are given both inside and around the thumb carpometacarpal joint, while the last two are administered only around the joint. Injections are performed weekly using sterile techniques with specific syringes and needles. The study measures the effects of this treatment at multiple time points: baseline (day 0), three weeks, six weeks, and sixteen weeks after starting treatment. Throughout the study, participants will undergo evaluations including pain assessments using the Visual Analogue Scale, functional tests such as the Disability of the Arm Shoulder and Hand score, and strength measurements like the Pinch Strength Test. Researchers will also monitor analgesic use through diaries and track any adverse events. These assessments will help determine the device's effectiveness in reducing pain and enhancing hand function over a 16-week period.
CONDITIONS
Official Title
Evaluation of the Performance and Safety of a Type I Collagen-Based Medical Device (MD-Small Joints Collagen Medical Device) i the Treatment of RHIZOARTROSIS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female subjects aged between 18 and 75 years
- Clinically diagnosed symptomatic thumb carpometacarpal osteoarthritis confirmed radiographically (stages I and II according to Eaton and Littler's classification)
- Pain score at least 5 on Visual Analogue Scale during hand use
- Thumb joint pain present for at least 1 month
- Not using thumb carpometacarpal orthotic devices
- Agreeing not to take analgesics within 24 hours before scheduled visits
- Able to understand and sign informed consent
You will not qualify if you...
- Rheumatological conditions involving the hands
- Previous hand surgery for the affected pathology
- Received hyaluronic acid injections in the thumb joint in the last 3 months
- Taken NSAIDs in the last 7 days or corticosteroids in the last 30 days
- Underwent physical therapies like X-ray, Tecar, shock wave, laser, or ultrasound in the last 3 months
- Presence of neoplastic pathology
- Having systemic infections
- Uncontrolled diabetes
- Neurological conditions affecting participation
- Coagulopathies or use of anticoagulants
- Under immunosuppressive treatment
- Use of drugs or alcohol abuse
- Allergy to porcine collagen
- Pregnant or breastfeeding women
- Participation in other clinical studies during the same period
- Unable to cooperate or expected poor compliance
- Any condition judged by investigator to require exclusion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ASST Grande Ospedale Metropolitano Niguarda Piazza dell'Ospedale Maggiore,
Milan, MI, Italy, 20135
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here